https://scholars.lib.ntu.edu.tw/handle/123456789/627228| Title: | Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma | Authors: | Chieh-Lung Cheng PO-TING YEH Fang, Wei-Quan WEI-LI MA HSIN-AN HOU Tsai, Cheng-Hong CHANG-PING LIN HWEI-FANG TIEN |
Keywords: | combination treatment; methotrexate; relapse; vitreoretinal lymphoma | Issue Date: | 5-Jan-2023 | Source: | Cancer medicine | Abstract: | The optimal treatment for vitreoretinal lymphoma (VRL) remains a challenge, as central nervous system (CNS) relapse occurs frequently, leading to the worst impact on survival. We previously proposed combined intravitreal methotrexate and systemic high-dose methotrexate therapy for this disease. This study aimed to report the long-term outcomes of patients with VRL using this combination treatment. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627228 | ISSN: | 2045-7634 2045-7634 |
DOI: | 10.1002/cam4.5609 |
| Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
